Home
About Us
Our Focus
Technology Platform
Service Portfolio

Cell-based Screening

Natural Products & Traditional Medicines Service

Lead Development Assays

Customised Assay Development

Contract Research & Development

Product Portfolio
R&D Partnership
Insights and News
Downloads
Contact

Service Portfolio /
Cell-based Screening

AvantiCell provides an 'off-the-shelf' cell-based screening service offering a range of cell types and assay readouts. The service is available for all level of sample throughput and sample composition.

Cell Types

For breast cancer applications, choose from:

Human breast cancer cell line HMT3909S8

Human luminal epithelial cell line 3.006

Human primary luminal epithelial cell line LEP-1

Human primary myoepithelial cell line MEP-1


For liver cancer applications, choose from:

Liver Hepatocarcinoma cell line HepG2

Liver primary hepatocyte (launch autumn 2009 - please enquire)


For neurodegeneration applications, choose:

UPS1 cell line (launch autumn 2009 - please enquire)

Assay Readouts

Readouts measuring generic parameters of cell health
(cell number, proliferation, apoptosis, cytotoxicity)
Readouts measuring neurodegeneration - choose
from screening options for preventive or remedial
therapeutics

Sample Throughput

96-multiwell plate format - analysis scalable from
single samples to multi-plate medium-throughput
screening

384-well plate format for high throughput - due for
launch winter 2009

Assay Performance

Sensitive, fluorescence intensity readout
Robust performance and reproducibility between
assays and projects

Service Delivery

Sample analysis and service delivery to tight
deadlines

Full data analysis and quality control using
appropriate assay controls
Report delivery in hard copy and electronic formats,
with optional oral presentation

E-mail this page to a Colleague

Leaders in Cell Culture
©AvantiCell Science 2009